25-Hydroxyvitamin-D levels in Sjögren’s syndrome: is it the right time to dismiss the case or not?
Makaleler > Tam Makale · 2024
Yazarlar: Gonca KARABULUT, Zevcet Yilmaz, Ilgın YILDIRIM ŞİMŞİR, Burcu BARUTÇUOĞLU, GÖKSEL TANIGÖR
Turkish Journal of Biochemistry, Uluslararası, Wos, 2024, cilt 49, ss 721-726
Özet
Abstract Objectives This study aimed to investigate whether patients with primary Sjögren syndrome (SjS) have different levels of 25 OH-D3 (vitamin D) when compared to healthy populations and whether differences in 25 OH-D3 correlated with disease activity or markers. Methods Eighty-eight female patients with SjS and 3,338 age-matched healthy female controls were included in this study. 25 OH-D3 levels were compared with healthy controls. Then the patients were stratified according to their 25 OH-D3 levels, either insufficient/deficient or normal (<50 nmol/L or ≥50 nmol/L). The disease activity was evaluated using The EULAR SjS disease activity index (ESSDAI) and its components. Correlation analyses were also performed for a possible correlation with disease characteristics and markers of activity. Results No differences in 25 OH-D3 levels were found between SjS and healthy populations (p>0.05). No correlations were found between patient characteristics or laboratory values (p>0.05). Conclusions This study did not find a link between disease characteristics and disease activity and 25 OH-D3 levels. Prospective studies with more patients should be conducted to reach a conclusion.